Zhejiang Garden Biopharmaceutical Co., Ltd. (300401.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 21Aug 26Aug 31Sep 3Sep 8Sep 11Sep 16Sep 21

Key dataSep 21, 2026

OpenCNY 16.45

From 52W high−37.18%

Volume23.64M

Market capCNY 7.70B

P/E (TTM)25.3x

P/S (TTM)7.7x

Div yield0.67%

Key dataSep 21, 2026

Open

CNY 16.45

From 52W high

−37.18%

Volume

23.64M

Market cap

CNY 7.70B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

15.8x

P/E (TTM)

25.3x

RSI (14)

62.3

MomentumView details →

1D Return

−8.42%

YTD Return

+11.18%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

25.3x

EV/EBITDA

15.8x

EV/Sales

7.0x

P/S (TTM)

7.7x

P/B (TTM)

2.3x

ProfitabilityView details →

Gross Margin

53.73%

Net Margin

21.77%

EBITDA Margin

44.48%

ROE (TTM)

7.30%

ROA (TTM)

4.30%

Asset Turnover

0.20x

GrowthView details →

Revenue YoY

−4.16%

EPS YoY

−18.64%

FCF YoY

+1696.21%

Revenue CAGR 3Y

−4.43%

EPS CAGR 3Y

−7.17%

EBITDA YoY

—

MomentumView details →

1D Return

−8.42%

YTD Return

+11.18%

1Y Return

+19.05%

RSI (14)

62.3

vs 50D SMA

+16.66%

vs 200D SMA

+10.69%

Capital & dividendView details →

Debt/Equity

0.20x

Current Ratio

2.08x

Quick Ratio

1.47x

Div Yield

0.67%

Div Rate

CNY 0.11

Div Growth 1Y

−0.88%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.19B

Net Income (TTM)

258.62M

Op. CF (TTM)

530.30M

Latest newsMore news →

Garden Bio disclosed its semi-annual report on August 14, reporting first-half net profit attributable to shareholders of 132 million yuan, down 18.34% year-on-year.39d ago

Garden Bio received a Drug Manufacturing License from Zhejiang Province Medical Products Administration, valid until August 9, 2031, marking its first such license and passing GMP compliance inspection.40d ago

Similar companies

久之洋300516.SZ 壹连科技301631.SZ 盟固利301487.SZ 旷达科技002516.SZ 中集环科301559.SZ 北京科锐002350.SZ Find similar companies →

Latest newsMore news →

Garden Bio disclosed its semi-annual report on August 14, reporting first-half net profit attributable to shareholders of 132 million yuan, down 18.34% year-on-year.39d ago Garden Bio received a Drug Manufacturing License from Zhejiang Province Medical Products Administration, valid until August 9, 2031, marking its first such license and passing GMP compliance inspection.40d ago